APPLICATIONS PUBLISHED 12 NOVEMBER 2003
Published: 1-May-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Cosmetic and/or pharmaceutical agent comprising acylated amino acids
Cognis Deutschland 1359884*
Oral drug delivery system
United Pharmaceuticals Manufacturing Co 1359898*
Compsn and method for controlled release injections
Cambridge Biostability 1359899*
A stable pharmaceutical formulation comprising torsemide modification
Teva Pharmaceutical Industries 1359900*
Thermolabile liposome with controlled release temperature
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1359901*
Bimodal dry powder formulation for inhalation
Innovata Biomed 1359902*
Method and device for producing thin wafers from a film of active ingredients
LTS Lohmann Therapie-Systeme 1359903*
P27 prevents cellular migration
The Trustees of Columbia University in the City of New York 1359904*
Use of MGLUR5 antagonists for the treatment of pruritic conditions
Novartis 1359905*
Pharmaceutical compsns containing fluorinated or perfluorinated carboxylic acids
CXR Biosciences 1359906*
Combination comprising an insulin secretion enhancer and an active ingredient selected from HMG-CoA reductase inhibitors and ACE inhibitors
Novartis 1359907*
Quinolines and nitrogenated derivatives thereof substituted by a piperidine-containing moiety and their use as antibacterial agents
SmithKline Beecham 1359908*
Anticancer treatment using triptolide prodrugs
Pharmagenesis 1359909*
Method for treating glaucoma II B
Alteon 1359910*
Method for treating fibrotic diseases and other indications IVC
Alteon 1359911*
Novel methods using pyridine derivatives
Eisai 1359912*
Thrombin inhibitors
Merck 1359913*
Novel therapeutic use of a thienyl-cyclohexylamine derivative
Societe de Conseils de Recherches et d'Applications Scientifiques 1359914*
Urotensin-II receptor antagonists
SmithKline Beecham 1359915*
Imidazolyl derivatives as corticotropin releasing factor inhibitors
Bristol-Myers Squibb 1359916*
Thioxazinoquinolones useful for the treatment of viral infections
Pharmacia & Upjohn 1359917*
Method for treating glaucoma IIB
Alteon 1359918*
Method of treating substance abuse with quetiapine
AstraZeneca 1359919*
Methods and formulations for the treatment of female sexual dysfunction
Endeavor Pharmaceuticals 1359920*
Methods to treat autoimmune and inflammatory conditions
NewBiotics 1359921*
Novel receptors for Heliobacter pylori and use thereof
Biotie Therapies 1359922*
Use of selenite or preparations containing selenite for treating wounds
Okopharm Forschungs- und Entwicklungs 1359923*
Endotoxin binding by lactic acid bacteria and bifidobacteria
Societe des Produits Nestle 1359924*
A method to enhance the immune system and use for the prevention and treatment of asthma
Ecarma, Virgilio 1359925*
An anti-diabetic agent obtained from the plant Humboldtia decurrens and a process for preparing the same
Council of Scientific and Industrial Research; Sree Chitra Tirunal Institute for Medical Sciences and Technology; Kerala Institute for Research, Training and Development Studies of Scheduled Castes and Scheduled Tribes 1359926*
Herbal pharmaceutical compsns for treating immunological disorders
Sun Ten Pharmaceuticals 1359927*
Medicinal and cosmetic uses of HOP and co-enzyme Q10
Van de Wiel, Adriaan; Christiaans, Marjike 1359928*
Phytotherapeutic compsn for eliminating heavy metals
Sun Nutrition 1359929*
Novisprins: antimicrobial peptides
The Regents of the University of California; University of Iowa Research Foundation 1359930*
Prevention of diabetes by administration of GNRH antagonists
Children's Mercy Hospital 1359931*
TIP39 peptides
The General Hospital Corp 1359932*
Treatment of demyelinating diseases by administering GPE
Neuronz 1359933*
Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
Neurotell 1359934*
Combined use of factor VII polypeptides and factor IX polypeptides
Novo Nordisk Health Care 1359935*
Combined use of factor VII polypeptides and factor VIII polypeptides
Novo Nordisk Health Care 1359936*
Altered peptide ligands
Genzyme Corp 1359937*
Method for treating psoriasis by using an IL-17D antagonist
ZymoGenetics 1359938*
Compsn and method for potentiating drugs
Genvys Pharmaceuticals 1359939*
Combinations of statins, estrogenic agents and optionally estrogens
Wyeth 1359940*
Albumin-based drug delivery system and antimicrobial peptides
King's College London 1359941*
Targeted anti-tumour drug delivery systems
Schering 1359942*
Biotin-derivates and their conjugates with chelating agents
Sigma-Tau Industrie Farmaceutiche Riunite 1359943*
Sterile polymerisable systems and kits and methods of their manufacture and use
Vita Special Purpose Corp 1359944*
Symmetrically disubstituted aromatic compounds and pharmaceutical compsns for inhibiting poly (ADP-ribose)glycohydrolase, and methods for their use
Guilford Pharmaceuticals 1360167*
Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
Ben Gurion University of the Negev Research and Development Authority 1360168*
Succinate salt of O-desmethyl-venlafaxane
Wyeth 1360169*
Carboxylic amides, the production and use thereof as medicaments
Boehringer Ingelheim Pharma 1360170*
Novalak cyanate-based prepolymer compsns
Lonza 1360171*
Trisubstituted carboxylic cyclophilin binding compounds and their use
Guilford Pharmaceuticals 1360173*
Phenethanolamine derivatives for treatment of respiratory diseases
Glaxo Group 1360174*
1G()-amino0N-hydroxy-acetamide derivatives
Novartis 1360175*
Pyrrolecarboxamides for use as fungicides
Syngenta Participations 1360176*
Oligomeric hindered amine light stabilisers based on multi-functional carbonyl compounds and methods of making same
Cytec Technology 1360177*
Novel heterocyclic analogues of diphenylethylene compounds
Calyx Therapeutics 1360178*
Methods for preparing compounds derived from thiazolidinedione, oxazolidinione or hydantoin
PPG-Sipsy 1360179*
Phenothiazine kinesin inhibitors
Cytokinetics 1360180*
